XM does not provide services to residents of the United States of America.
M
M

Metso

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Metso Gets Repeat Orders Worth EUR 14 Mln

BRIEF-Metso Gets Repeat Orders Worth EUR 14 Mln Oct 3 (Reuters) - Metso Oyj METSO.HE : GETS REPEAT ORDERS FOR SUPPLY OF MILL LINING SOLUTIONS TO AFRICA VALUE OF ORDERS CIRCA EUR 14 MILLION Further company coverage: METSO.HE (Gdansk Newsroom)
M

Bureau Veritas, Covestro AG, Redcare Pharmacy NV

EUROPE RESEARCH ROUNDUP-Bureau Veritas, Covestro AG, Redcare Pharmacy NV Oct 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bureau Veritas, Covestro AG and Redcare Pharmacy NV, on Wednesday. HIGHLIGHTS * British Land BLND.L : Deutsche Bank raises to buy from hold * Bureau Veritas BVI.PA : JP Morgan cuts to neutral from overweight * Covestro AG 1COV.DE : Jefferies cuts to hold from buy * Redcare Pharmacy NV RDC.DE : HSBC raises t
A
A
A
B
B
B
D
E
E
E
E
E
E
E
F
G
I
M
M
A
A
A
A
B
B
E
G
Z

Metso To Deliver Copper Tailings Dewatering Plant Unit In Africa

BRIEF-Metso To Deliver Copper Tailings Dewatering Plant Unit In Africa Oct 1 (Reuters) - Metso Oyj METSO.HE : TO DELIVER COPPER TAILINGS DEWATERING PLANT UNIT IN AFRICA TOTAL VALUE OF ORDER EXCEEDS EUR 20 MILLION Further company coverage: METSO.HE (Gdansk Newsroom)
M

Metso Secures Order Of About EUR 70 Mln

BRIEF-Metso Secures Order Of About EUR 70 Mln Sept 30 (Reuters) - Metso Oyj METSO.HE : SECURES MAJOR CONTRACT FOR KEY PROCESS EQUIPMENT AT BARRICK’S LUMWANA COPPER PROJECT IN ZAMBIA VALUE OF ORDER IS ABOUT EUR 70 MILLION Further company coverage: METSO.HE (Gdansk Newsroom)
M

Metso Gets Order For Iron Ore Pelletizing Plant In China

BRIEF-Metso Gets Order For Iron Ore Pelletizing Plant In China Sept 25 (Reuters) - Metso Oyj METSO.HE : GETS ORDER FOR IRON ORE PELLETIZING PLANT IN CHINA Source text: https://www.metso.com/corporate/media/news/2024/9/metso-wins-order-for-iron-ore-pelletizing-plant-in-china/ Further company coverage: METSO.HE (Gdansk Newsroom)
M

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.